Advertisement

Topics

Seasonal Influenza Vaccines 5EU Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $6995

11:15 EST 28 Feb 2017 | BioPortfolio Reports

Seasonal Influenza Vaccines 5EU Drug Forecast and Market Analysis to 2025

Summary

Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection's rapid onset and potential for high morbidity and mortality, particularly in highrisk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza.

A quadrivalent formulation of Intanza Intradermal is anticipated to be launched in the EU, following the launch of quadrivalent Fluzone Intradermal in the US. The sales of quadrivalent Intanza Intradermal are expected to increase to $1.5m in 2025. Its growth will be driven by its improved immunogenicity in elderly patients compared to typical influenza vaccines and the increase in the size of Germany's elderly population.

*This is an ondemand report and will be delivered within 24 hrs. excluding weekends of the purchase.

Scope

Overview of Seasonal Influenza Vaccines including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
Detailed information on the key drugs in 5EU including product description, safety and efficacy profiles as well as a SWOT analysis.
Sales forecast for the top drugs in 5EU from 20152025.
Analysis of the impact of key events as well the drivers and restraints affecting 5EU Seasonal Influenza Vaccines market.

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return
Stay ahead of the competition by understanding the changing competitive landscape for Seasonal Influenza Vaccines.
Effectively plan your MA and partnership strategies by identifying drugs with the most promising sales potential
Make more informed business decisions from insightful and indepth analysis of drug performance
Obtain sales forecast for drugs from 20152025 in 5EU.

Original Article: Seasonal Influenza Vaccines 5EU Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $6995

NEXT ARTICLE

More From BioPortfolio on "Seasonal Influenza Vaccines 5EU Drug Forecast and Market Analysis to 2025 [Updated: 01112016] Prices from USD $6995"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Influenza
Influenza or 'flu' is a respiratory illness associated with infection by influenza virus. Symptoms frequently include headache, fever, cough, sore throat, aching muscles and joints. There is a wide spectrum of severity of illness ranging from min...